Abstract
Genetic and early environmental differences including early health habits associate with future health. To provide insight on the causal nature of these associations, monozygotic (MZ) twin pairs discordant for health habits provide an interesting natural experiment. Twin pairs discordant for leisure-time physical activity (LTPA) in early adult life are thus a powerful study design to investigate the associations between long-term LTPA and indicators of health and wellbeing. We have used this study design by identifying 17 LTPA discordant twin pairs from two Finnish twin cohorts and summarize key findings of these studies in this paper. The carefully characterized rare long-term LTPA discordant MZ twin pairs have participated in multi-dimensional clinical examinations. The occurrence of type 2 diabetes and death has been evaluated on the basis of prospective questionnaire data and register follow-up among a larger number of twin pairs. Key findings highlight that, compared to less active twins in such MZ twin pairs, the twins with higher long-term LTPA have higher physical fitness, reduced body fat, reduced visceral fat, reduced liver fat, increased lumen diameters of conduit arteries to the lower limbs, increased bone mineral density in loaded bone areas, increased high-density lipoprotein cholesterol levels and reduced occurrence of type 2 diabetes. However, we have not been able to document differences in the life expectancy between the less and more active twin siblings of the LTPA discordant MZ twin pairs. The findings are in agreement with intervention studies but not with all observational studies in which genetic factors are not controlled for.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Main funding of the substudies: TWINACTIVE study: The Finnish Ministry of Education and Culture (grant to UMK), Academy of Finland (grant to UMK), Finnish Cultural Foundation (grant to TL), Juho Vainio Foundation (grants to UMK, TL and SA) and Yrjo Jahnnsson Foundation (grant to SA). FITFATTWIN study: The Finnish Ministry of Education and Culture (UMK), META-PREDICT (within the European Union Seventh Framework Program, HEALTH-F2-2012-277936 to UMK), Juho Vainio Foundation (MR), and Finnish Cultural Foundation (MR). MOBILETWIN study: The Finnish Ministry of Education and Culture (grant OKM/56/626/2013 to UMK). The Finnish Twin Cohort Study has been supported by multiple grants over the past 45 years, including grants from the Academy of Finland (to JK) and NIH (to JK and Richard J Rose for FinnTwin16). The current grant (# 336823) from the Academy of Finland supporting JK is specifically acknowledged. MAK is supported by a research grant from the Sigrid Juselius Foundation, Finland.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This is a (pooled) summary of different twin studies and the details of the ethics committee statements are given in the articles cited in the manuscript. All the studies and their procedures that contributed to this summary review complied with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All participating twins provided informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
